{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:15:54Z","timestamp":1793834154468,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>IgA nephropathy (IgAN) and IgA vasculitis with nephritis (IgAVN) are related glomerular diseases characterized by marked similarities in immunological and histological findings. We herein performed a comparative proteomic analysis of glomerular proteins in IgAN and IgAVN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used renal biopsy specimens from 6 IgAN patients without nephrotic syndrome (NS) (IgAN-I subgroup), 6 IgAN patients with NS (IgAN-II subgroup), 6 IgAVN patients with 0\u20138.0% of glomeruli with crescent formation (IgAVN-I subgroup), 6 IgAVN patients with 21.2\u201344.8% of glomeruli with crescent formation (IgAVN-II subgroup), 9 IgAVN patients without NS (IgAVN-III subgroup), 3 IgAVN patients with NS (IgAN-IV subgroup), and 5 control cases. Proteins were extracted from laser microdissected glomeruli and analyzed using mass spectrometry. The relative abundance of proteins was compared between groups. An immunohistochemical validation study was also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>More than 850 proteins with high confidence were identified. A principal component analysis revealed a clear separation between IgAN and IgAVN patients and control cases. In further analyses, 546 proteins that were matched with \u2265\u20092 peptides were selected. The levels of immunoglobulins (IgA, IgG, and IgM), complements (C3, C4A, C5, and C9), complement factor H-related proteins (CFHR) 1 and 5, vitronectin, fibrinogen chains, and transforming growth factor-\u03b2 inducible gene-h3 were higher (&gt;\u20092.6 fold) in the IgAN and IgAVN subgroups than in the control group, whereas hornerin levels were lower (&lt;\u20090.3 fold). Furthermore, C9 and CFHR1 levels were significantly higher in the IgAN group than in the IgAVN group. The abundance of some podocyte-associated proteins and glomerular basement membrane (GBM) proteins was significantly less in the IgAN-II subgroup than in the IgAN-I subgroup as well as in the IgAVN-IV subgroup than in the IgAVN-III subgroup. Among the IgAN and IgAVN subgroups, talin 1 was not detected in the IgAN-II subgroup. This result was supported by immunohistochemical findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present results suggest shared molecular mechanisms for glomerular injury in IgAN and IgAVN, except for enhanced glomerular complement activation in IgAN. Differences in the protein abundance of podocyte-associated and GBM proteins between IgAN and IgAVN patients with and without NS may be associated with the severity of proteinuria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12014-023-09409-w","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T04:02:29Z","timestamp":1683950549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Hajime","family":"Kaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumito","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoshi","family":"Dohmae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Odaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Komatsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"9409_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran A, Julian BA, Rizk DV. IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci. 2021;361:176\u201394.","journal-title":"Am J Med Sci"},{"key":"9409_CR2","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/ndt\/gfy413","volume":"34","author":"H Trimarchi","year":"2019","unstructured":"Trimarchi H, Coppo R. Podocytopathy in the mesangial proliferative immunoglobulin a nephropathy: new insights into the mechanisms of damage and progression. Nephrol Dial Transplant. 2019;34:1280\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"9409_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00467-021-04950-y","volume":"37","author":"MC Hastings","year":"2022","unstructured":"Hastings MC, Rizk DV, Kiryluk K, Nelson R, Zahr RS, Novak J, et al. IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol. 2022;37:719\u201333.","journal-title":"Pediatr Nephrol"},{"key":"9409_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","volume":"93","author":"H Suzuki","year":"2018","unstructured":"Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93:700\u20135.","journal-title":"Kidney Int"},{"key":"9409_CR5","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/jcm10112310","volume":"10","author":"E Pillebout","year":"2021","unstructured":"Pillebout E. IgA vasculitis and IgA nephropathy: same disease? J Clin Med. 2021;10:2310.","journal-title":"J Clin Med"},{"key":"9409_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1620\/tjem.240.199","volume":"240","author":"A Saito","year":"2016","unstructured":"Saito A, Komatsuda A, Kaga H, Sato R, Togashi M, Okuyama S, et al. Different expression patterns of toll-like receptor mRNAs in blood mononuclear cells of IgA nephropathy and IgA vasculitis with nephritis. Tohoku J Exp Med. 2016;240:199\u2013208.","journal-title":"Tohoku J Exp Med"},{"key":"9409_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s10157-020-01898-5","volume":"24","author":"R Miyakawa","year":"2020","unstructured":"Miyakawa R, Sato A, Matsuda Y, Saito A, Abe F, Matsumura H, et al. Comparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice. Clin Exp Nephrol. 2020;24:666\u201379.","journal-title":"Clin Exp Nephrol"},{"key":"9409_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12014-022-09365-x","volume":"19","author":"H Kaga","year":"2022","unstructured":"Kaga H, Matsumura H, Suzuki T, Dohmae N, Odaka M, Komatsuda A, et al. Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy. Clin Proteomics. 2022;19:26.","journal-title":"Clin Proteomics"},{"key":"9409_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12953-019-0155-y","volume":"17","author":"A Taherkhani","year":"2019","unstructured":"Taherkhani A, Farrokhi Yekta R, Mohseni M, Saidijam M, Arefi Oskouie A. Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers. Proteome Sci. 2019;17:7.","journal-title":"Proteome Sci"},{"key":"9409_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12014-020-09274-x","volume":"17","author":"X Fang","year":"2020","unstructured":"Fang X, Wu H, Lu M, Cao Y, Wang R, Wang M, et al. Urinary proteomics of Henoch-Sch\u00f6nlein purpura nephritis in children using liquid chromatography-tandem mass spectrometry. Clin Proteomics. 2020;17:10.","journal-title":"Clin Proteomics"},{"key":"9409_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12014-017-9165-x","volume":"14","author":"TIF Paunas","year":"2017","unstructured":"Paunas TIF, Finne K, Leh S, Marti HP, Mollnes TE, Berven F, et al. Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy. Clin Proteomics. 2017;14:30.","journal-title":"Clin Proteomics"},{"key":"9409_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12882-019-1598-1","volume":"20","author":"FTI Paunas","year":"2019","unstructured":"Paunas FTI, Finne K, Leh S, Osman TA, Marti HP, Berven F, et al. Characterization of glomerular extracellular matrix in IgA nephropathy by proteomic analysis of laser-captured microdissected glomeruli. BMC Nephrol. 2019;20:410.","journal-title":"BMC Nephrol"},{"key":"9409_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/nep.13676","volume":"25","author":"N Kawata","year":"2020","unstructured":"Kawata N, Kang D, Aiuchi T, Obama T, Yoshitake O, Shibata T, et al. Proteomics of human glomerulonephritis by laser microdissection and liquid chromatography-tandem mass spectrometry. Nephrology (Carlton). 2020;25:351\u20139.","journal-title":"Nephrology (Carlton)"},{"key":"9409_CR14","doi-asserted-by":"publisher","first-page":"103979","DOI":"10.1016\/j.jprot.2020.103979","volume":"230","author":"X Fang","year":"2021","unstructured":"Fang X, Lu M, Xia Z, Gao C, Cao Y, Wang R, et al. Use of liquid chromatography-tandem mass spectrometry to perform urinary proteomic analysis of children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura nephritis. J Proteomics. 2021;230:103979.","journal-title":"J Proteomics"},{"key":"9409_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69: 798\u2013806.","journal-title":"Ann Rheum Dis"},{"key":"9409_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u2013682.","journal-title":"Nat Methods"},{"key":"9409_CR17","doi-asserted-by":"publisher","first-page":"103669","DOI":"10.1016\/j.jprot.2020.103669","volume":"215","author":"L Zhao","year":"2020","unstructured":"Zhao L, Cong X, Zhai L, Hu H, Xu JY, Zhao W, et al. Comparative evaluation of label-free quantification strategies. J Proteomics. 2020;215:103669.","journal-title":"J Proteomics"},{"key":"9409_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1399-0039.2006.00613.x","volume":"68","author":"BD Wines","year":"2006","unstructured":"Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens. 2006;68:103\u201314.","journal-title":"Tissue Antigens"},{"key":"9409_CR19","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.4049\/jimmunol.1601864","volume":"198","author":"M Papanastasiou","year":"2017","unstructured":"Papanastasiou M, Koutsogiannaki S, Sarigiannis Y, Geisbrecht BV, Ricklin D, Lambris JD. Structural implications for the formation and function of the complement effector protein iC3b. J Immunol. 2017;198:3326\u201335.","journal-title":"J Immunol"},{"key":"9409_CR20","doi-asserted-by":"publisher","first-page":"101627","DOI":"10.1016\/j.smim.2022.101627","volume":"59","author":"BV Geisbrecht","year":"2022","unstructured":"Geisbrecht BV, Lambris JD, Gros P. Complement component C3: a structural perspective and potential therapeutic implications. Semin Immunol. 2022;59:101627.","journal-title":"Semin Immunol"},{"key":"9409_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"JB Kopp","year":"2020","unstructured":"Kopp JB, Anders HJ, Susztak K, Podest\u00e0 MA, Remuzzi G, Hildebrandt F, et al. Podocytopathies. Nat Rev Dis Primers. 2020;6:68.","journal-title":"Podocytopathies. Nat Rev Dis Primers"},{"key":"9409_CR22","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/cells9071700","volume":"9","author":"J Blaine","year":"2020","unstructured":"Blaine J, Dylewski J. Regulation of the actin cytoskeleton in podocytes. Cells. 2020;9:1700.","journal-title":"Cells"},{"key":"9409_CR23","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/JCI69778","volume":"124","author":"X Tian","year":"2014","unstructured":"Tian X, Kim JJ, Monkley SM, Gotoh N, Nandez R, Soda K, et al. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance. J Clin Invest. 2014;124: 1098\u2013113.","journal-title":"J Clin Invest"},{"key":"9409_CR24","doi-asserted-by":"publisher","first-page":"20137","DOI":"10.1074\/jbc.M109.099481","volume":"285","author":"TJ van Duijn","year":"2010","unstructured":"van Duijn TJ, Anthony EC, Hensbergen PJ, Deelder AM, Hordijk PL. Rac1 recruits the adapter protein CMS\/CD2AP to cell-cell contacts. J Biol Chem. 2010;285:20137\u201346.","journal-title":"J Biol Chem"},{"key":"9409_CR25","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1681\/ASN.2019121261","volume":"31","author":"X Ge","year":"2020","unstructured":"Ge X, Zhang T, Yu X, Muwonge AN, Anandakrishnan N, Wong NJ, et al. LIM-nebulette reinforces podocyte structural integrity by linking actin and vimentin filaments. J Am Soc Nephrol. 2020;31:2372\u201391.","journal-title":"J Am Soc Nephrol"},{"key":"9409_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","volume":"17","author":"RW Naylor","year":"2021","unstructured":"Naylor RW, Morais MRPT, Lennon R. Complexities of the glomerular basement membrane. Nat Rev Nephrol. 2021;17:112\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"9409_CR27","first-page":"495","volume":"47","author":"Y Nakamoto","year":"1978","unstructured":"Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, et al. Primary IgA glomerulonephritis and Sch\u00f6nlein-Henoch purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med. 1978;47:495\u2013516.","journal-title":"Q J Med"},{"key":"9409_CR28","doi-asserted-by":"publisher","first-page":"e0232194","DOI":"10.1371\/journal.pone.0232194","volume":"15","author":"M Sugiyama","year":"2020","unstructured":"Sugiyama M, Wada Y, Kanazawa N, Tachibana S, Suzuki T, Matsumoto K, et al. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Sch\u00f6nlein purpura nephritis and IgA nephropathy. PLoS One. 2020;15:e0232194.","journal-title":"PLoS One"},{"key":"9409_CR29","first-page":"129","volume":"157","author":"H Suzuki","year":"2007","unstructured":"Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, et al. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. Contrib Nephrol. 2007;157:129\u201333.","journal-title":"Contrib Nephrol"},{"key":"9409_CR30","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1172\/JCI109998","volume":"66","author":"ME Conley","year":"1980","unstructured":"Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980;66:1432\u20136.","journal-title":"J Clin Invest"},{"key":"9409_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1523-1755.2001.00476.x","volume":"59","author":"S Moll","year":"2001","unstructured":"Moll S, Miot S, Sadallah S, Gudat F, Mihatsch MJ, Schifferli JA. No complement receptor 1 stumps on podocytes in human glomerulopathies. Kidney Int. 2001;59:160\u20138.","journal-title":"Kidney Int"},{"key":"9409_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molimm.2019.07.017","volume":"114","author":"A Tortajada","year":"2019","unstructured":"Tortajada A, Gutierrez E, Pickering MC, Praga Terente M, Medjeral-Thomas N. The role of complement in IgA nephropathy. Mol Immunol. 2019;114:123\u201332.","journal-title":"Mol Immunol"},{"key":"9409_CR33","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1097\/01.ASN.0000078803.53165.C9","volume":"14","author":"K Koop","year":"2003","unstructured":"Koop K, Eikmans M, Baelde HJ, Kawachi H, de Heer E, Paul LC, et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol. 2003;14:2063\u201371.","journal-title":"J Am Soc Nephrol"},{"key":"9409_CR34","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1074\/jbc.M112.427484","volume":"288","author":"AM Manso","year":"2013","unstructured":"Manso AM, Li R, Monkley SJ, Cruz NM, Ong S, Lao DH, et al. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload. J Biol Chem. 2013;288:4252\u201364.","journal-title":"J Biol Chem"},{"key":"9409_CR35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00424-017-2025-8","volume":"469","author":"K Endlich","year":"2017","unstructured":"Endlich K, Kliewe F, Endlich N. Stressed podocytes\u2013\u2013mechanical forces, sensors, signaling and response. Pflugers Arch. 2017;469:937\u201349.","journal-title":"Pflugers Arch"},{"key":"9409_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.23876\/j.krcp.20.017","volume":"39","author":"JH Lee","year":"2020","unstructured":"Lee JH, Jang SH, Cho NJ, Heo NH, Gil HW, Lee EY, et al. Severity of foot process effacement is associated with proteinuria in patients with IgA nephropathy. Kidney Res Clin Pract. 2020;39:295\u2013304.","journal-title":"Kidney Res Clin Pract"},{"key":"9409_CR37","doi-asserted-by":"publisher","first-page":"F333","DOI":"10.1152\/ajprenal.00478.2012","volume":"304","author":"W Kriz","year":"2013","unstructured":"Kriz W, Shirato I, Nagata M, LeHir M, Lemley KV. The podocyte\u2019s response to stress: the enigma of foot process effacement. Am J Physiol Renal Physiol. 2013;304:F333\u201347.","journal-title":"Am J Physiol Renal Physiol"},{"key":"9409_CR38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ndt\/gfv325","volume":"31","author":"C Gast","year":"2016","unstructured":"Gast C, Pengelly RJ, Lyon M, Bunyan DJ, Seaby EG, Graham N, et al. Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2016;31:961\u201370.","journal-title":"Nephrol Dial Transplant"},{"key":"9409_CR39","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1681\/ASN.2010060632","volume":"22","author":"YM Chen","year":"2011","unstructured":"Chen YM, Kikkawa Y, Miner JH. A missense LAMB2 mutation causes congenital nephrotic syndrome by impairing laminin secretion. J Am Soc Nephrol. 2011;22: 849\u201358.","journal-title":"J Am Soc Nephrol"},{"key":"9409_CR40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10157-018-1619-6","volume":"23","author":"R Katafuchi","year":"2019","unstructured":"Katafuchi R, Nagae H, Masutani K, Tsuruya K, Mitsuiki K. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy. Clin Exp Nephrol. 2019;23:169\u201381.","journal-title":"Clin Exp Nephrol"},{"key":"9409_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13052-018-0538-1","volume":"44","author":"F Wang","year":"2018","unstructured":"Wang F, Huang L, Tang H, Li X, Zhu X, Wang X. Significance of glomerular fibrinogen deposition in children with Henoch-Sch\u00f6nlein purpura nephritis. Ital J Pediatr. 2018;44:97.","journal-title":"Ital J Pediatr"},{"key":"9409_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2215\/CJN.06910520","volume":"16","author":"XJ Zhou","year":"2021","unstructured":"Zhou XJ, Tsoi LC, Hu Y, Patrick MT, He K, Berthier CC, et al. Exome chip analyses and genetic risk for IgA nephropathy among Han Chinese. Clin J Am Soc Nephrol. 2021;16:213\u201324.","journal-title":"Clin J Am Soc Nephrol"},{"key":"9409_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/exd.14482","volume":"31","author":"E Christophers","year":"2022","unstructured":"Christophers E, Schr\u00f6der JM. Evolution of innate defense in human skin. Exp Dermatol. 2022;31:304\u201311.","journal-title":"Exp Dermatol"},{"key":"9409_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/MNH.0000000000000596","volume":"29","author":"L Anguiano","year":"2020","unstructured":"Anguiano L, Kain R, Anders HJ. The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hypertens. 2020;29:302\u20139.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"9409_CR45","doi-asserted-by":"publisher","first-page":"833954","DOI":"10.3389\/fphys.2022.833954","volume":"13","author":"S Xu","year":"2022","unstructured":"Xu S, Han S, Dai Y, Wang L, Zhang X, Ding Y. A review of the mechanism of vascular endothelial injury in immunoglobulin A vasculitis. Front Physiol. 2022;13:833954.","journal-title":"Front Physiol"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-023-09409-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-023-09409-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-023-09409-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T05:02:57Z","timestamp":1683954177000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-023-09409-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["9409"],"URL":"https:\/\/doi.org\/10.1186\/s12014-023-09409-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2203200\/v1","asserted-by":"object"}]},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]},"assertion":[{"value":"25 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committees of Akita University Hospital (approval number: 1830) and the RIKEN Center (approval number: Wako3 2019-17), and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We agree to the publication of this manuscript upon its acceptance and that all copyright ownership for the article will be transferred to Clinical Proteomics. The material submitted is new, original, and has not been submitted to another journal for concurrent consideration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Naoto Takahashi received grants and personal fees from Novartis Pharmaceuticals, Pfizer, and Otsuka Pharmaceutical and grants from Kyowa Kirin, Astellas Pharma, Asahi Kasei Pharma, Ono Pharmaceutical, and Mochida Pharmaceuticals outside of the submitted work. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}